Balyasny Asset Management »

Protalix Biotherapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $16k 13k 1.17

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Protalix Biotherapeutics

Renaissance Technologies
Goldman Sachs Group
GSA Capital Partners
BlackRock
Stratos Wealth Partners
Bridgeway Capital Management
BlackRock
Citadel Advisors
Squarepoint Ops
Qube Research & Technologies
Morgan Stanley
Susquehanna International
Orin Green Financial
Two Sigma Securities
Northern Trust

View all funds holding Protalix Biotherapeutics